Found: 7
Select item for more details and to access through your institution.
Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 757, doi. 10.1002/pds.4809
- By:
- Publication type:
- Article
The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 711, doi. 10.2147/PPA.S101175
- By:
- Publication type:
- Article
Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 12, p. 5649, doi. 10.1007/s12325-021-01930-4
- By:
- Publication type:
- Article
Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 1, p. 187, doi. 10.1007/s40744-022-00504-2
- By:
- Publication type:
- Article
Economic Burden of Switching to Different Biologic Therapies Among Tumor Necrosis Factor Inhibitor-Experienced Patients with Psoriatic Arthritis.
- Published in:
- Rheumatology & Therapy, 2019, v. 6, n. 2, p. 285, doi. 10.1007/s40744-019-0158-2
- By:
- Publication type:
- Article
Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
- Published in:
- Epilepsia (Series 4), 2009, v. 50, n. 3, p. 493, doi. 10.1111/j.1528-1167.2008.01703.x
- By:
- Publication type:
- Article